These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37278449)

  • 1. Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
    Futagami S; Kessoku T; Kasai Y; Higurashi T; Nakajima A; Agawa S; Yamawaki H; Nakamura K; Habiro M; Kawawa R; Ueki N; Higashida S; Watanabe Y; Yamato H; Yamamoto T; Takasaki Y; Ito K; Hojo M; Isayama H; Motoda N; Ohashi R; Siah KTH; Ng CK; Gwee KA
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1778-1786. PubMed ID: 37278449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.
    Agawa S; Futagami S; Yamawaki H; Tsushima R; Higuchi K; Habiro M; Kawawa R; Kodaka Y; Ueki N; Watanabe Y; Gudis K; Ohashi R; Iwakiri K
    PLoS One; 2022; 17(10):e0275341. PubMed ID: 36264979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
    von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
    Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
    Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
    Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
    Edwards T; Friesen C; Schurman JV
    BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
    Andreev DN; Bordin DS; Vyuchnova ES; Lebedeva EG; Dicheva DT; Umyarova RM; Maev IV
    Ter Arkh; 2022 Oct; 94(9):1099-1108. PubMed ID: 36286762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
    J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-Up Study.
    Barberio B; Yiannakou Y; Houghton LA; Black CJ; Savarino EV; Ford AC
    Clin Gastroenterol Hepatol; 2022 Feb; 20(2):e89-e101. PubMed ID: 33839276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.
    Perveen I; Rahman MM; Saha M; Rahman MM; Hasan MQ
    Indian J Gastroenterol; 2014 May; 33(3):265-73. PubMed ID: 24664445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population.
    Rasmussen S; Jensen TH; Henriksen SL; Haastrup PF; Larsen PV; Søndergaard J; Jarbøl DE
    Scand J Gastroenterol; 2015 Feb; 50(2):162-9. PubMed ID: 25525975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Irritable Bowel Syndrome, Functional Dyspepsia and their Overlap in Bulgaria: a Population-Based Study.
    Nakov R; Dimitrova-Yurukova D; Snegarova V; Uzunova M; Lyutakov I; Ivanova M; Madzharova K; Valkov H; Hristova R; Ivanov K; Kosturkov I; Valcheva G; Nakov N; Nakov V
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):329-338. PubMed ID: 32919417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.
    Talley NJ; Holtmann G; Walker MM; Burns G; Potter M; Shah A; Jones M; Koloski NA; Keely S
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00064. PubMed ID: 31356481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symptom overlaps between functional heartburn, functional dyspepsia, and irritable bowel syndrome].
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):489-92. PubMed ID: 24941825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
    Kotani S; Fukuba N; Kawashima K; Mishima Y; Sonoyama H; Okimoto E; Tada Y; Oka A; Tamagawa Y; Oshima N; Mishiro T; Tobita H; Shibagaki K; Moriyama I; Ishimura N; Kushiyama Y; Fujishiro H; Ishihara S
    Scand J Gastroenterol; 2020 May; 55(5):560-564. PubMed ID: 32412797
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.
    Burns G; Carroll G; Mathe A; Horvat J; Foster P; Walker MM; Talley NJ; Keely S
    Am J Gastroenterol; 2019 Mar; 114(3):429-436. PubMed ID: 30839392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia.
    Shah A; Gurusamy SR; Hansen T; Callaghan G; Talley NJ; Koloski N; Walker MM; Jones MP; Morrison M; Holtmann GJ
    Dig Dis Sci; 2022 Jun; 67(6):2299-2309. PubMed ID: 34392491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.